Drug-Eluting Balloon Market Research Report 2022 – Global Forecast to 2027: New Developments in Clinical Use of Drug-Coated Balloon Catheters and Extensive Preclinical and Clinical R&D – ResearchAndMarkets.com | Nation/World


The “Drug Eluting Balloon Market Research Report by Type (Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon), Coating Technology, End User, Region (Americas, Asia-Pacific, and Europe, Middle East and Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19 report has been added to ResearchAndMarkets.com’s offering.

The global Drug Eluting Balloons market size was estimated to be USD 675.45 million in 2021, USD 807.16 million in 2022, and is projected to grow at a compound annual growth rate (CAGR) of 19.67% for reach USD 1,984.51 million by 2027.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.

Cumulative impact of COVID-19:

The report provides insights into COVID-19 considering shifts in consumer behavior and demand, shopping patterns, supply chain rerouting, current market force dynamics, and significant interventions governments. The updated study provides insights, analysis, estimates, and forecasts considering the impact of COVID-19 on the market.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors of the Drug Eluting Balloon Market based on business strategy (business growth, industry coverage, financial viability, and channel support) and customer satisfaction. product (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others.

Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Competitive scenario:

The competitive scenario provides an analysis of the prospects of the various business growth strategies adopted by the vendors. The news covered in this section provides valuable insights at various stages while keeping abreast of business news and engaging stakeholders in the economic debate.

Enterprise Usability Profiles:

  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and company
  • Biotronik SE & Co. KG
  • Boston Scientific Society
  • Cook Medical, Inc.
  • Eurocor GmbH
  • Koninklijke Philips NV
  • Medtronic AG
  • Terumo Company

Main topics covered:

1. Preface

1.1. Study objectives

1.2. Market segmentation and coverage

1.3. Years Considered for Study

1.4. Currency and price

1.5. Tongue

1.6. Boundaries

1.7. Hypotheses

1.8. Stakeholders

2. Research methodology

2.1. Define: research objective

2.2. Determine: research design

2.3. Prepare: finding aid

2.4. Collect: Data Source

2.5. Analysis: Interpretation of data

2.6. Formula: data verification

2.7. Publish: Research Report

2.8. Repeat: report update

3. Executive Summary

4. Market Overview

5. Market Overview

5.1. Market dynamics

5.1.1. Drivers Increased prevalence of peripheral arterial and coronary artery disease Increase in geriatric population leading to cardiovascular disease

5.1.2. Constraints Huge cost of developing and commercializing drug-eluting balloons Adverse reactions and product recalls

5.1.3. Opportunities New Developments in the Clinical Use of Drug-Coated Balloon Catheters Extensive preclinical and clinical research and product development Advancement and Innovation in Drug Coated Balloons

5.1.4. Challenges Risks and technical issues

5.2. Cumulative impact of COVID-19

5.3. Cumulative impact of the 2022 Russian-Ukrainian conflict

6. Drug Eluting Balloons Market, By Type

6.1. Introduction

6.2. Drug Eluting Coronary Balloon

6.3. Drug Eluting Peripheral Balloon

7. Drug Eluting Balloons Market, By Coating Technology

7.1. Introduction

7.2. Endura Coat

7.3. FreePac

7.4. Paccocath

7.5. TransPax

8. Drug Eluting Balloons Market, By End User

8.1. Introduction

8.2. Ambulatory surgery centers

8.3. Catheterization laboratories

8.4. Hospitals

9. Americas Drug Eluting Balloons Market

9.1. Introduction

9.2. Argentina

9.3. Brazil

9.4. Canada

9.5. Mexico

9.6. United States

10. Asia Pacific Drug Eluting Balloon Market

11. Europe, Middle East and Africa Drug Eluting Balloon Market

12. Competitive landscape

12.1. FPNV positioning matrix

12.2. Market Ranking Analysis

12.3. Market share analysis, by key player

12.4. Competitive scenario

13. Enterprise Usability Profiles

For more information about this report visit https://www.researchandmarkets.com/r/x9sagd

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220516005569/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Officer


For EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900



SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 05/16/2022 07:38 / DISK: 05/16/2022 07:38